FDA finds bits of steel, rubber in Genzyme drugs

Nov 13, 2009
FILE - In this May 28, 2008 file photo, Genzyme's Manufacturing Facility is seen, in the Allston neighborhood of Boston. Federal health regulators said Friday, Nov. 13, 2009, they have found tiny particles of trash in drugs made by biotechnology firm Genzyme. (AP Photo/Bizuayehu Tesfaye, file)

(AP) -- Federal health regulators have found tiny particles of trash in drugs made by biotechnology firm Genzyme.

The said Friday that bits of steel, rubber and fiber found in vials of drugs used to treat rare enzyme disorders could cause serious adverse health effects for patients.

Shares of Genzyme Corp. dropped $3.12, or 5.9 percent, to $50.05 in afternoon trading.

The FDA announcement is the second case of contamination for the Cambridge, Mass.-based company this year. In June, Genzyme was forced to shut down a key production facility due to viral contamination.

Calls placed to Genzyme Friday afternoon were not immediately returned.

The drugs affected by the latest announcement include: Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen.

The FDA estimates the contamination only affects about 1 percent of Genzyme's products, and no adverse events have been reported to the government.

The agency is not removing the products from the market because it said there are few alternative treatments.

FDA regulators say doctors should closely inspect vials for particles before injecting them into patients.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Xtoro approved for swimmer's ear

add to favorites email to friend print save as pdf

Related Stories

FDA: Arthritis drugs pose cancer risk to children

Aug 04, 2009

(AP) -- Federal regulators on Tuesday added stronger warnings to a group of best-selling drugs used to treat arthritis and other inflammatory diseases, saying they can increase the risk of cancer in children and adolescents.

FDA requires faster food safety reporting

Sep 08, 2009

(AP) -- Food makers will be required to alert government officials of potentially contaminated products within 24 hours under a new rule designed to help federal regulators spot food safety issues sooner.

FDA issues supplement rules

Jun 23, 2007

The U.S. Food and Drug Administration has issued new government standards for the manufacture of vitamins and dietary supplements.

Recommended for you

Xtoro approved for swimmer's ear

6 hours ago

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

7 hours ago

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

Judge halts Alzheimer's drug swap until July

Dec 16, 2014

A federal judge has ordered an Irish drug manufacturer to halt its plans to discontinue its widely used Alzheimer's medication, allegedly in an effort to drive patients to a newer patented drug.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.